Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00811655 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00811655 is a Phase 2 study that was terminated before completion, run by Duke University. The registered enrollment target is 6 participants.
The verdict
NCT00811655, a Phase 2 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is studying how well stereotactic radiosurgery works in treating patients with brain metastases.
Interventions
- PROCEDURE therapeutic conventional surgery
- RADIATION stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00811655
The ClinicalTrials.gov registry entry for NCT00811655 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which therapeutic conventional surgery is the first listed.
NCT00811655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00811655 about?
NCT00811655 is a clinical study titled "Stereotactic Radiosurgery in Treating Patients With Brain Metastases". RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is s...
What is the current status of trial NCT00811655?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2008-10. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00811655?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00811655?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.